Lisa Drew
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Cell death mechanisms and regulation 7
- Ubiquitin and proteasome pathways 5
- Melanoma and MAPK Pathways 5
- Protein Degradation and Inhibitors 5
- Oncology 27
- Cancer-related Molecular Pathways 14
- Co-authors
- Jamal Saeh (5 shared papers)Alice T. Shaw (2 shared papers)Jeffrey A. Engelman (2 shared papers)Ryohei Katayama (2 shared papers)Mari Mino–Kenudson (1 shared paper)Katherine Crosby (1 shared paper)John C. Wain (1 shared paper)Balázs Halmos (1 shared paper)
- Journals
- Cancer Research (10 papers)Blood (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Cancer Immunology Research (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Lisa Drew
56 papers receiving 2.3k citations
Lisa Drew's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 873
- Cancer Research 287
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 261
Countries citing papers authored by Lisa Drew
This map shows the geographic impact of Lisa Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Drew more than expected).
Fields of papers citing papers by Lisa Drew
This network shows the impact of papers produced by Lisa Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Drew. The network helps show where Lisa Drew may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers Hit paper breakdown → | 2012 | 1014 |
| 2 | 2008 | 426 | |
| 3 | 2020 | 89 | |
| 4 | 2001 | 83 | |
| 5 | 2003 | 65 | |
| 6 | 2019 | 53 | |
| 7 | 2011 | 42 | |
| 8 | 2019 | 40 | |
| 9 | The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. | 2002 | 37 |
| 10 | Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. | 2003 | 37 |
| 11 | 2018 | 36 | |
| 12 | 1998 | 27 | |
| 13 | 2022 | 24 | |
| 14 | 2019 | 22 | |
| 15 | 2013 | 21 | |
| 16 | 2008 | 21 | |
| 17 | 1999 | 21 | |
| 18 | 2020 | 19 | |
| 19 | 1998 | 19 | |
| 20 | 2007 | 18 |
About Lisa Drew
Lisa Drew is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Hematology, having authored 56 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Ubiquitin and proteasome pathways (5 papers), Melanoma and MAPK Pathways (5 papers), Protein Degradation and Inhibitors (5 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Oncology (1.0k citations), Pulmonary and Respiratory Medicine (873 citations), Cancer Research (287 citations), Molecular Biology (1.3k citations) and Pathology and Forensic Medicine (261 citations). Lisa Drew has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Jamal Saeh, Alice T. Shaw, Jeffrey A. Engelman, Ryohei Katayama, Mari Mino–Kenudson, Katherine Crosby, John C. Wain, Balázs Halmos, Lecia V. Sequist and Benjamin Solomon. Their work appears in journals such as Cancer Research, Blood, Bioorganic & Medicinal Chemistry Letters, Cancer Immunology Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.